Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment: the TRIPLACE Registry

Status: Recruiting
Location: See all (21) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients undergoing Transcatheter Tricuspid Valve Replacement

• Native Tricuspid Valve disease

• Orthotopic Tricuspid Valve Implantation

Locations
United States
Arizona
Arizona Heart Hospital (Biltmore Cardiology)
RECRUITING
Phoenix
New York
Columbia University Irving Medical Center
RECRUITING
New York
Montefiore Medical Center
RECRUITING
The Bronx
Ohio
Cleveland Clinic
RECRUITING
Cleveland
Oregon
Oregon Health & Science University
ENROLLING_BY_INVITATION
Portland
Other Locations
Canada
Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
RECRUITING
Québec
St Michael's Hospital, University of Toronto
RECRUITING
Toronto
St. Paul's Hospital
RECRUITING
Vancouver
Denmark
Rigshospitalet, Copenhagen University Hospital
RECRUITING
Copenhagen
France
Chu De Bordeaux - Haut-Lévêque Hospital
RECRUITING
Bordeaux
Centre Hospitalier Universitaire de Lille
RECRUITING
Lille
Clinique Pasteur Toulouse
RECRUITING
Toulouse
Germany
Heart and Diabetes Centre, North Rhine-Westphalia (NRW), Ruhr-University
RECRUITING
Bad Oeynhausen
Heart Center Cologne, University of Cologne
RECRUITING
Cologne
Cardiovascular Center (CVC) Frankfurt, Division of Cardiology
RECRUITING
Frankfurt
University Heart and Vascular Center, Department of Cardiology
RECRUITING
Hamburg
University Heart Center, Schleswig-Holstein University
RECRUITING
Lübeck
Medical Clinic and Polyclinic, University Hospital of Munich (LMU Klinikum)
RECRUITING
Munich
Italy
Centro Cardiologico Monzino IRCCS
RECRUITING
Milan
San Raffaele University Hospital
RECRUITING
Milan
Spain
University Hospital Alvaro Cunqueiro (CHUVI)
RECRUITING
Vigo
Contact Information
Primary
Andrea Scotti, MD
ascotti@montefiore.org
7189043388
Backup
Rishi Puri, MD
purir@ccf.org
(216) 444-2273
Time Frame
Start Date: 2023-10-05
Estimated Completion Date: 2026-08
Participants
Target number of participants: 800
Treatments
Patients with Tricuspid Regurgitation undergoing Transcatheter Tricuspid Valve Replacement
Patients having clinically significant tricuspid regurgitation, defined according to current guidelines (ESC/EACTS and ACC/AHA) for valvular heart disease, requiring transcatheter tricuspid valve replacement
Related Therapeutic Areas
Sponsors
Collaborators: The Cleveland Clinic, University Hospital, Bordeaux, University of Toronto
Leads: Montefiore Medical Center

This content was sourced from clinicaltrials.gov